This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2024 Related Topics
Insurance Coverage and Processing Biosimilars Controlled Substances Pharmaceutical Manufacturing Packaging Drug Pricing Labelling Documentation Pharmaceutical Calculations Communication More Related Topics >
article thumbnail

STAT’s 2024 Diversity and Inclusion Report

STAT

OCTOBER 30, 2024

The STAT Diversity and Inclusion Committee presents STAT’s 2024 Diversity and Inclusion Report. Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2023, as well as our 2023 new hire demographics. 

256
256
article thumbnail

Opinion: STAT+: Four leading biopharma executives weigh the 2024 election

STAT

OCTOBER 24, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. Read  Read an excerpt from each below.

Pharmaceutical Companies 239
Pharmaceutical Companies Pharmaceutical Companies 239
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2024 Nobel prize in medicine: Ruvkun, Ambros win for discovery of microRNA

STAT

OCTOBER 7, 2024

LONDON — A pair of scientists who discovered a type of RNA molecule that helps control the activity of genes — allowing our cells to perform all their myriad of functions in different tissues throughout the body — won the 2024 Nobel Prize in medicine or physiology on Monday.

362
362
article thumbnail

Baylor wins 2024 STAT Madness with ‘smoke alarm’ for viral disease outbreaks

STAT

APRIL 4, 2024

Their study demonstrating the power of sewage as an early-warning system for outbreaks won the 2024 STAT Madness popular vote. Building off that early polio work from the 1940s, researchers from the Baylor College of Medicine analyzed public wastewater and showed they could detect over 450 disease-causing viruses. Read the rest…

353
353
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

📆 November 21, 2024 at 11:00 AM PST, 2:00 PM EST, 7:00 PM GMT

article thumbnail

The 2024 PharmaVoice 100

PharmaVoice

OCTOBER 8, 2024

This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.

363
363
article thumbnail

Opinion: STAT+: What the Sandoz CEO is thinking about the 2024 elections

STAT

OCTOBER 15, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration.    With all eyes currently on the upcoming U.S.

Pharmaceutical Companies 228
Pharmaceutical Companies Pharmaceutical Companies Drug Development 228
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

📅 October 15, 2024 at 11:00 am PT, 2:00 pm ET, 7:00 pm GMT Don’t miss this exclusive session - register today to save your seat!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 11,000+ Insiders by signing up for our newsletter

About
Webinars
About
Editions
Webinars
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024